The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta‐review of meta‐analyses of randomized controlled trials

IF 60.5 1区 医学 Q1 PSYCHIATRY World Psychiatry Pub Date : 2019-10-01 DOI:10.1002/wps.20672
J. Firth, S. Teasdale, K. Allott, D. Siskind, W. Marx, J. Cotter, N. Veronese, F. Schuch, Lee Smith, M. Solmi, A. Carvalho, D. Vancampfort, M. Berk, B. Stubbs, J. Sarris
{"title":"The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta‐review of meta‐analyses of randomized controlled trials","authors":"J. Firth, S. Teasdale, K. Allott, D. Siskind, W. Marx, J. Cotter, N. Veronese, F. Schuch, Lee Smith, M. Solmi, A. Carvalho, D. Vancampfort, M. Berk, B. Stubbs, J. Sarris","doi":"10.1002/wps.20672","DOIUrl":null,"url":null,"abstract":"The role of nutrition in mental health is becoming increasingly acknowledged. Along with dietary intake, nutrition can also be obtained from “nutrient supplements”, such as polyunsaturated fatty acids (PUFAs), vitamins, minerals, antioxidants, amino acids and pre/probiotic supplements. Recently, a large number of meta‐analyses have emerged examining nutrient supplements in the treatment of mental disorders. To produce a meta‐review of this top‐tier evidence, we identified, synthesized and appraised all meta‐analyses of randomized controlled trials (RCTs) reporting on the efficacy and safety of nutrient supplements in common and severe mental disorders. Our systematic search identified 33 meta‐analyses of placebo‐controlled RCTs, with primary analyses including outcome data from 10,951 individuals. The strongest evidence was found for PUFAs (particularly as eicosapentaenoic acid) as an adjunctive treatment for depression. More nascent evidence suggested that PUFAs may also be beneficial for attention‐deficit/hyperactivity disorder, whereas there was no evidence for schizophrenia. Folate‐based supplements were widely researched as adjunctive treatments for depression and schizophrenia, with positive effects from RCTs of high‐dose methylfolate in major depressive disorder. There was emergent evidence for N‐acetylcysteine as a useful adjunctive treatment in mood disorders and schizophrenia. All nutrient supplements had good safety profiles, with no evidence of serious adverse effects or contraindications with psychiatric medications. In conclusion, clinicians should be informed of the nutrient supplements with established efficacy for certain conditions (such as eicosapentaenoic acid in depression), but also made aware of those currently lacking evidentiary support. Future research should aim to determine which individuals may benefit most from evidence‐based supplements, to further elucidate the underlying mechanisms.","PeriodicalId":49357,"journal":{"name":"World Psychiatry","volume":" ","pages":""},"PeriodicalIF":60.5000,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/wps.20672","citationCount":"124","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/wps.20672","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 124

Abstract

The role of nutrition in mental health is becoming increasingly acknowledged. Along with dietary intake, nutrition can also be obtained from “nutrient supplements”, such as polyunsaturated fatty acids (PUFAs), vitamins, minerals, antioxidants, amino acids and pre/probiotic supplements. Recently, a large number of meta‐analyses have emerged examining nutrient supplements in the treatment of mental disorders. To produce a meta‐review of this top‐tier evidence, we identified, synthesized and appraised all meta‐analyses of randomized controlled trials (RCTs) reporting on the efficacy and safety of nutrient supplements in common and severe mental disorders. Our systematic search identified 33 meta‐analyses of placebo‐controlled RCTs, with primary analyses including outcome data from 10,951 individuals. The strongest evidence was found for PUFAs (particularly as eicosapentaenoic acid) as an adjunctive treatment for depression. More nascent evidence suggested that PUFAs may also be beneficial for attention‐deficit/hyperactivity disorder, whereas there was no evidence for schizophrenia. Folate‐based supplements were widely researched as adjunctive treatments for depression and schizophrenia, with positive effects from RCTs of high‐dose methylfolate in major depressive disorder. There was emergent evidence for N‐acetylcysteine as a useful adjunctive treatment in mood disorders and schizophrenia. All nutrient supplements had good safety profiles, with no evidence of serious adverse effects or contraindications with psychiatric medications. In conclusion, clinicians should be informed of the nutrient supplements with established efficacy for certain conditions (such as eicosapentaenoic acid in depression), but also made aware of those currently lacking evidentiary support. Future research should aim to determine which individuals may benefit most from evidence‐based supplements, to further elucidate the underlying mechanisms.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
营养补充剂治疗精神障碍的疗效和安全性:随机对照试验荟萃分析的荟萃综述
营养在心理健康中的作用越来越得到人们的认可。除了饮食摄入外,还可以从“营养补充剂”中获得营养,如多不饱和脂肪酸(PUFA)、维生素、矿物质、抗氧化剂、氨基酸和益生菌前补充剂。最近,出现了大量的荟萃分析,研究营养补充剂在治疗精神障碍中的作用。为了对这一顶级证据进行荟萃分析,我们确定、合成并评估了随机对照试验(RCT)的所有荟萃分析,这些试验报告了营养补充剂对常见和严重精神障碍的疗效和安全性。我们的系统搜索确定了33项安慰剂对照随机对照试验的荟萃分析,主要分析包括10951名个体的结果数据。最有力的证据是PUFA(特别是二十碳五烯酸)是抑郁症的辅助治疗药物。更多的初步证据表明,PUFA也可能对注意力缺陷/多动障碍有益,而没有证据表明它对精神分裂症有益。叶酸补充剂作为抑郁症和精神分裂症的辅助治疗方法被广泛研究,高剂量甲基叶酸对重度抑郁症的随机对照试验具有积极作用。有新的证据表明,N-乙酰半胱氨酸是情绪障碍和精神分裂症的有用辅助治疗药物。所有营养补充剂都具有良好的安全性,没有证据表明存在严重的不良反应或精神药物禁忌症。总之,临床医生应了解对某些疾病(如抑郁症患者的二十碳五烯酸)具有既定疗效的营养补充剂,但也应了解目前缺乏证据支持的营养补充剂。未来的研究应旨在确定哪些人可能从基于证据的补充剂中受益最大,以进一步阐明潜在机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
World Psychiatry
World Psychiatry 医学-精神病学
自引率
7.40%
发文量
124
期刊介绍: World Psychiatry is the official journal of the World Psychiatric Association. It is published in three issues per year. The journal is sent free of charge to psychiatrists whose names and addresses are provided by WPA member societies and sections. World Psychiatry is also freely accessible on Wiley Online Library and PubMed Central. The main aim of World Psychiatry is to disseminate information on significant clinical, service, and research developments in the mental health field. The journal aims to use a language that can be understood by the majority of mental health professionals worldwide.
期刊最新文献
Augmenting trauma-focused cognitive behavior therapy for post-traumatic stress disorder with memory specificity training: a randomized controlled trial. Changing approaches to interventions for autistic adults. Dispelling "pleasing myths" about the integration of ecological momentary assessment and intervention into clinical research and practice. Effectiveness of a stepped-care programme of WHO psychological interventions in a population of migrants: results from the RESPOND randomized controlled trial. The current clinical approach to feeding and eating disorders aimed to increase personalization of management.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1